Opus Genetics, Inc. (IRD) Tops Q2 EPS by 2c

Opus Genetics, Inc. (NASDAQ: IRD) reported Q2 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.

You May Also Be Interested In

• Oracle (ORCL) PT Lowered to $290 at Jefferies
• Piper Sandler Starts Red Cat Holdings Inc. (RCAT) at Neutral
• Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance